NCT02176161View on ClinicalTrials.gov

Metformin Prostate Cancer Adjuvant Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

July 21, 2021

Study Completion Date

July 21, 2021

Conditions
Prostate CancerProstate Cancer Recurrent
Interventions
DRUG

Metformin Hydrochloride Extended Release 750mg

Metformin Hydrochloride Extended Release 750mg twice per day for 9 months.

Trial Locations (1)

11501

Winthrop University Hospital, Mineola

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02176161 - Metformin Prostate Cancer Adjuvant Trial | Biotech Hunter | Biotech Hunter